510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K032693Substantially Equivalent

Duragen Plus Dural Graft Matrix

Integra LifeSciences Corporation, Planisboro NJ / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K032693 is the FDA 510(k) clearance record for DURAGEN PLUS DURAL GRAFT MATRIX, a class II device, cleared for Integra Lifesciences Corp. on under FDA product code GXQ (Dura Substitute). FDA records list 94 510(k) clearances for Integra Lifesciences Corp., from to . As of , FDA records show one recall naming K032693.

Clearance record

Decision date
Received
(28 days to decision)
Product code
GXQ Dura Substitute
Regulation
21 CFR 882.5910
Device class
Class II
Review panel
Neurology
Applicant
Integra Lifesciences Corp. 311 Enterprise Dr., Planisboro NJ
510(k) summary
Summary PDF
Third party review
No

Clearances, product code GXQ

Trailing 12 months
1 clearance under product code GXQ in the twelve months to October 2026, November 2025 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code GXQ, trailing twelve months
MonthClearances
November 20251
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260